Nitric oxide is a short-lived gaseous signaling molecule involved in vascular regulation, neurotransmission, oxygen delivery, immunity, respiration, mitochondrial function, and sleep–wake control. The body maintains nitric oxide through two complementary systems: the endogenous nitric oxide synthase pathway and the dietary nitrate–nitrite–nitric oxide pathway. The endogenous pathway produces nitric oxide enzymatically from L-arginine but requires oxygen and multiple cofactors. The alternative pathway begins with dietary nitrate and depends substantially on nitrate-reducing bacteria within the oral microbiome. Because the conversion of nitrite to nitric oxide is enhanced under low-oxygen and acidic conditions, this pathway may provide compensatory support when endogenous nitric oxide synthesis is impaired. The paranasal sinuses provide an additional endogenous source of nitric oxide that is delivered toward the lungs during nasal breathing. Mouth breathing, nasal obstruction, oral dryness, poor vegetable intake, oral dysbiosis, aging, oxidative stress, and sleep-disordered breathing may therefore compromise overlapping elements of nitric oxide physiology. A slowly dissolving prebiotic nitrate lozenge provides a rational means of supporting the oral microbial step in nitric oxide production. The MyFitStrip™ nitric oxide platform was designed to place nitrate directly in contact with nitrate-reducing oral bacteria and extend its residence time within the mouth. Its underlying slow-release delivery strategy has been evaluated in a randomized, double-blind, placebo-controlled clinical trial demonstrating increased salivary nitric oxide-related activity, enrichment of nitrate-reducing bacteria, increased oral pH, and reduced gingival inflammation. The MyFitStrip™ lozenge translates this clinically studied mechanism into a practical, slowly dissolving dosage form. Its potential contribution to nocturnal nitric oxide availability is biologically plausible, direct clinical studies are still required to establish effects on sleep quality, sleep architecture, nocturnal oxygenation, snoring, or obstructive sleep apnea. Shawn J. Green, PhD, shawnjgreen@myfitstrip.com MyFitStrip LLC, clinically validated prebiotic nitric oxide company Introduction Sleep is often viewed primarily as a neurological process. In reality, restorative sleep depends on the integration of the brain, respiratory system, cardiovascular system, metabolism, immune function, and the microorganisms living within the body. Nitric oxide sits at the intersection of these systems. Nitric oxide is produced throughout the body and acts as a local signaling molecule. It relaxes vascular smooth muscle, regulates blood flow, influences platelet activity, participates in neurotransmission, supports immune defense, affects mitochondrial respiration, and contributes to communication among neurons, blood vessels, airway tissues, and immune cells [1–4]. Nitric oxide also participates in the regulation of sleep and wakefulness. It is involved in sleep pressure, adenosine signaling, cortical slow-wave activity, cerebral blood-flow regulation, and interactions between sleep and immune function [5–9]. The body does not store large quantities of nitric oxide because the molecule is highly reactive and short-lived. Instead, nitric oxide must be continually generated where and when it is needed. Two complementary pathways accomplish this: 1. The endogenous L-arginine–nitric oxide synthase pathway. 2. The dietary nitrate–nitrite–nitric oxide pathway. A third important component is respiratory: nitric oxide produced in the nose and paranasal sinuses is carried toward the lungs during nasal breathing [20–25]. Together, these systems connect the brain, vasculature, breathing, diet, saliva, and the oral microbiome. Understanding their interaction provides a new framework for considering how nitric oxide availability may influence sleep physiology. The Endogenous Nitric Oxide Synthase Pathway The classical endogenous pathway produces nitric oxide enzymatically from the amino acid L-arginine. The reaction is catalyzed by nitric oxide synthase and requires molecular oxygen, nicotinamide adenine dinucleotide phosphate, tetrahydrobiopterin, flavins, calmodulin, and other cofactors [1,2]. Three principal nitric oxide synthase isoforms are recognized. o Endothelial nitric oxide synthase, or eNOS, produces nitric oxide within vascular endothelial cells. It helps regulate blood-vessel relaxation, tissue perfusion, blood pressure, platelet activity, vascular inflammation, and endothelial integrity [1,2]. o Neuronal nitric oxide synthase, or nNOS, is expressed in neurons, skeletal muscle, airway tissue, and other cell types. It participates in neurotransmission, neurovascular coupling, central respiratory regulation, muscle function, and sleep–wake signaling [2,5]. o Inducible nitric oxide synthase, or iNOS, is activated primarily during immune and inflammatory responses. In contrast to the smaller and more tightly regulated quantities generated by eNOS and nNOS, iNOS can produce larger amounts of nitric oxide for longer periods [1,2]. Under healthy conditions, eNOS and nNOS provide localized and carefully regulated nitric oxide signaling. This pathway, however, has several vulnerabilities. Nitric oxide synthase depends on oxygen. It also depends on adequate cofactors and a favorable redox environment. Aging, oxidative stress, inflammation, diabetes, hypertension, obesity, smoking, vascular disease, and cofactor depletion can reduce nitric oxide production or cause nitric oxide synthase to become uncoupled. In an uncoupled state, the enzyme produces superoxide rather than nitric oxide, further reducing nitric oxide bioavailability and increasing oxidative stress [2–4]. This limitation is especially relevant when oxygen availability falls. Under hypoxic conditions, the enzymatic pathway may become less efficient at the same time nitric oxide is needed to support vasodilation, tissue perfusion, and oxygen delivery. Hence, dietary pathway becomes critical. Nitric Oxide in Sleep–Wake Regulation Nitric oxide is not merely a vascular molecule operating during sleep. It also participates in the neurological regulation of sleep itself [5,6]. Neurons expressing nNOS are located in several brain regions involved in sleep and arousal, including the cerebral cortex, basal forebrain, hypothalamus, and brainstem. Experimental evidence indicates that nitric oxide contributes to the accumulation of sleep pressure during prolonged wakefulness and to the initiation of recovery sleep following sleep deprivation [5–9]. In the basal forebrain, sleep deprivation induces iNOS-dependent nitric oxide production. This increase in nitric oxide contributes to the subsequent accumulation of extracellular adenosine, one of the principal biochemical mediators of homeostatic sleep pressure [7,8]. Certain cortical neurons expressing nNOS become especially active during sleep and are associated with the slow-wave activity characteristic of deep non-rapid-eye-movement sleep [9]. Nitric oxide may therefore help connect prior neuronal activity with the local and global processes that promote restorative sleep. Potential roles of nitric oxide in sleep include: • Promoting sleep pressure after prolonged wakefulness. • Interacting with adenosine signaling. • Modulating cortical slow-wave activity. • Supporting cerebral blood flow and neurovascular coupling. • Influencing autonomic and respiratory control. • Mediating interactions between immune activation and sleep. The relationship is not simply “more nitric oxide is better.” Healthy physiology depends on nitric oxide being produced in the appropriate location, concentration, and time. The objective is therefore not indiscriminate nitric oxide elevation. It is preservation or restoration of normal nitric oxide biology. The Dietary Nitrate–Nitrite–Nitric Oxide Pathway The body has a second pathway that complements nitric oxide synthase. This alternative pathway begins with inorganic nitrate obtained primarily from vegetables such as arugula, spinach, lettuce, beetroot, celery, Swiss chard, bok choy, and radish [3,4]. After nitrate is ingested, it is absorbed through the gastrointestinal tract and enters the circulation. Approximately 20% to 25% of circulating nitrate is actively concentrated by the salivary glands and secreted back into the mouth [3,10,11]. Human cells do not efficiently perform the first step required to activate nitrate. That reaction depends substantially on nitrate-reducing bacteria living on the tongue and other oral surfaces. These bacteria convert nitrate into nitrite [10–13]. Nitrite-rich saliva is then swallowed. Within the acidic environment of the stomach, some nitrite is converted into nitric oxide and other bioactive nitrogen oxides. Additional nitrite enters the circulation, where it serves as a relatively stable reservoir from which nitric oxide can be generated in tissues [3,4,10]. The conversion of nitrite to nitric oxide can occur through reactions involving deoxygenated hemoglobin, myoglobin, xanthine oxidoreductase, mitochondrial proteins, and other metalloproteins and reductases [3,4]. Importantly, many of these reactions become more active when oxygen tension and pH fall. The two pathways therefore possess reciprocal oxygen dependencies: • Nitric oxide synthase requires oxygen to generate nitric oxide. • Nitrite reduction becomes more favorable as oxygen availability decreases. This is why the dietary nitrate pathway may become especially important when endogenous nitric oxide generation is impaired by hypoxia, oxidative stress, endothelial dysfunction, or aging. Why the Exogenous Pathway May Be Important During Sleep Respiratory drive and minute ventilation normally decline during sleep. Upper-airway muscle tone also falls, particularly during rapid-eye-movement sleep. In healthy individuals, these changes are generally well tolerated. In susceptible individuals, however, they may contribute to snoring, upper-airway narrowing, reduced ventilation, and intermittent hypoxia. Obstructive sleep apnea represents the most pronounced example. Recurrent airway collapse produces repeated cycles of oxygen deprivation and reoxygenation. These cycles increase sympathetic activity, inflammation, oxidative stress, and vascular dysfunction while reducing nitric oxide bioavailability [27–31]. The nitrate–nitrite pathway may be relevant during sleep for several reasons. o First, nitrate and nitrite are more stable than nitric oxide and can circulate as reservoirs available for later activation. o Second, nitrite reduction is enhanced under low-oxygen conditions. The pathway can therefore produce nitric oxide preferentially in tissues experiencing reduced oxygen availability. o Third, nitrate-derived nitric oxide supports vascular relaxation and may help regulate the distribution of blood flow. o Fourth, dietary nitrate has been shown to reduce the oxygen cost of physical work and influence mitochondrial efficiency [18,19]. Exercise studies do not establish that nitrate improves sleep, but they demonstrate that nitrate-derived nitric oxide can affect oxygen economy. o Fifth, the nitrate pathway can remain functional even when eNOS-dependent nitric oxide production is impaired. This pathway should not be viewed as a replacement for endogenous nitric oxide synthase. Rather, it functions as a complementary and partly compensatory system. Nasal Nitric Oxide The upper airway represents another important source of nitric oxide. Human paranasal sinuses produce exceptionally high concentrations of the molecule [20–22]. Nitric oxide accumulates within the sinus cavities and is released through the sinus openings into the nasal airway. During nasal breathing, sinus-derived nitric oxide is carried toward the lower respiratory tract with inspired air [20–25]. This has been described as an aerocrine mechanism: a gaseous signal is produced in one anatomical location and transported through airflow to influence another. Nasal nitric oxide may contribute to: • Pulmonary vascular regulation. • Ventilation–perfusion matching. • Oxygen uptake. • Mucociliary clearance. • Regulation of ciliary activity. • Local antimicrobial defense. • Maintenance of respiratory-tract physiology. Because inhaled nitric oxide reaches ventilated portions of the lungs, it can relax pulmonary blood vessels adjacent to well-aerated alveoli. This may help align pulmonary blood flow with regional ventilation. Small physiological studies have reported improved oxygenation during nasal breathing compared with oral breathing and have shown that sinus-derived nitric oxide can influence pulmonary vascular resistance [23,24]. Humming can transiently increase measured nasal nitric oxide by promoting gas exchange between the paranasal sinuses and nasal cavity [26]. This observation reinforces the concept that the sinuses serve as a substantial physiological reservoir of nitric oxide. Why Nasal Breathing Matters During Sleep The nose is not simply an alternative route for moving air. It warms, humidifies, and filters inspired air. It regulates airflow resistance, supports mucociliary clearance, and delivers sinus-derived nitric oxide toward the lungs. Mouth breathing bypasses these functions. It also increases evaporation from oral tissues, contributing to dryness, altered oral pH, reduced salivary protection, and changes in the physical environment of oral biofilms. Mouth breathing may therefore interfere with nitric oxide physiology through two distinct mechanisms. o First, it bypasses the nasal pathway by which sinus-derived nitric oxide normally reaches the respiratory tract. o Second, it may interfere with the oral pathway. The enterosalivary nitrate cycle requires saliva to transport nitrate to nitrate-reducing bacteria. Reduced salivary flow or oral dryness can diminish contact among nitrate, bacteria, and oral biofilms. Salivary flow naturally declines at night. Mouth breathing, nasal obstruction, medications, dehydration, aging, and leakage from positive-airway-pressure devices may reduce oral moisture further. Persistent mouth breathing can also be a sign of nasal obstruction, allergies, structural abnormalities, enlarged tonsils, or sleep-disordered breathing. These conditions require appropriate clinical evaluation. Nevertheless, maintaining nasal patency and normal nasal respiration may preserve both the respiratory contribution of sinus-derived nitric oxide and the salivary environment required for efficient nitrate metabolism. Nasal and Dietary Nitric Oxide Are Complementary Nasal nitric oxide and dietary nitrate operate in different but complementary anatomical compartments. Nasal nitric oxide is produced locally and delivered to the respiratory tract with each nasal breath. It may support pulmonary vascular function, oxygen exchange, mucociliary activity, and airway defense. Dietary nitrate enters the enterosalivary circulation and produces a longer-lasting systemic reservoir of nitrate and nitrite. This reservoir can support nitric oxide generation in the mouth, stomach, circulation, vasculature, muscle, and other tissues. During sleep, nasal breathing may provide a breath-by-breath source of nitric oxide to the respiratory tract, while nitrate-derived nitrite provides a hypoxia-responsive source of nitric oxide within tissues. Optimal nitric oxide physiology may therefore depend on several interacting factors: • Functional nitric oxide synthase enzymes. • Adequate nasal breathing. • Sufficient vegetable-derived nitrate. • Healthy salivary production. • An active nitrate-reducing oral microbiome. • A vascular environment with limited oxidative stress. Dietary Nitrate as Compensation Nitric oxide bioavailability commonly declines with age. It can also be reduced by hypertension, diabetes, obesity, smoking, sedentary behavior, vascular disease, chronic inflammation, and oxidative stress [2–4]. At the same time, many people consume insufficient quantities of nitrate-rich vegetables. Reduced endogenous production combined with inadequate dietary nitrate can limit both major nitric oxide pathways. Vegetables should remain the nutritional foundation. They provide nitrate together with vitamin C, polyphenols, fiber, minerals, and other compounds that support vascular and metabolic health. However, the nitrate content of vegetables varies substantially according to plant species, soil conditions, light exposure, harvesting, storage, and preparation. Daily nitrate intake may consequently be inconsistent even among people who consume vegetables regularly. Timing also matters. Dietary nitrate must be absorbed, concentrated into saliva, reduced by oral bacteria, swallowed, and recirculated. A nitrate-rich meal consumed early in the day may not create the same localized oral exposure immediately before the overnight fasting period. A controlled oral nitrate formulation may therefore complement—rather than replace—a vegetable-rich diet by providing a consistent dose and extended contact with nitrate-reducing bacteria. The Oral Microbiome as a Nitric Oxide-Producing System The oral microbiome is not merely a collection of microorganisms associated with plaque or dental disease. It is a metabolically active community that contributes to systemic physiology. Several oral bacterial genera contain species capable of reducing nitrate to nitrite, including: • Neisseria. • Rothia. • Actinomyces. • Veillonella. • Haemophilus. • Kingella. The posterior surface of the tongue is an especially important site for nitrate reduction, although nitrate-metabolizing organisms are also present elsewhere in the mouth [12,13]. The requirement for oral bacteria has been demonstrated experimentally. Antiseptic mouthwash markedly attenuates the increase in salivary and plasma nitrite following nitrate consumption. In some studies, suppressing the oral nitrate-reducing community also increased blood pressure [32–34]. These findings establish that oral bacteria perform a physiological reaction that human tissues conduct inefficiently. The oral microbiome can therefore be considered an essential component of a human–microbial nitric oxide-producing system. Nitrate-Vitamin C as an Oral Prebiotic Nitrate is more than a substrate that is passively converted to nitrite. It may also act as an oral prebiotic by selectively supporting bacteria and microbial functions associated with nitrate reduction. Human and laboratory studies have shown that sustained nitrate exposure can enrich health-associated nitrate-reducing organisms, particularly Neisseria and Rothia [35–39]. Nitrate reduction also influences oral chemistry. Studies have reported increases in oral pH and shifts away from excessive acidification following nitrate exposure [37–40]. This may support oral health by: • Reducing selection pressure for acid-tolerant organisms. • Supporting a more neutral oral environment. • Altering biofilm metabolism. • Increasing nitrite production. • Generating nitric oxide and related nitrogen species locally. • Potentially reducing the ecological conditions associated with caries and periodontal inflammation. Nitrate should not be described as a conventional broad-spectrum antimicrobial. Its principal value may be ecological: it supplies a metabolic substrate that favors beneficial microbial functions rather than attempting to sterilize the mouth. Sleep, Oral Dysbiosis, and Nitric Oxide Sleep disruption and oral dysbiosis may reinforce one another. Mouth breathing and reduced nocturnal salivary flow promote dryness and alter oral biofilm conditions. Sleep restriction and obstructive sleep apnea increase sympathetic activation, inflammatory signaling, oxidative stress, and impaired glucose regulation. Periodontal inflammation can add to systemic inflammatory and oxidative burden. Because vascular nitric oxide is readily consumed by reactive oxygen species, chronic oral inflammation may further reduce nitric oxide bioavailability. A plausible reinforcing cycle can therefore be proposed: 1. Poor sleep and mouth breathing increase oral dryness and physiological stress. 2. The oral environment becomes less favorable for salivary nitrate metabolism. 3. Oral nitrate-to-nitrite conversion may decline. 4. Nitrite and nitric oxide availability may be reduced. 5. Reduced nitric oxide contributes to endothelial and vascular dysfunction. 6. Vascular dysfunction and inflammation may further impair nocturnal recovery. This sequence remains a mechanistic hypothesis rather than a fully proven causal pathway. It nevertheless provides a scientifically coherent framework connecting oral health, sleep, respiration, and cardiovascular physiology. Why Localized Nitrate Delivery Matters A swallowed nitrate capsule can provide a reproducible dose, but it initially bypasses the oral bacteria responsible for nitrate activation. Absorbed nitrate may later return to the mouth through saliva, but the immediate oral microbial exposure is limited. A nitrate beverage exposes the mouth, but most of the nitrate is swallowed rapidly. A slowly dissolving lozenge offers a different delivery strategy. By remaining in the mouth for several minutes, it can place nitrate directly in contact with bacteria on the tongue and within oral biofilms. Extended oral residence time may: • Increase direct contact between nitrate and nitrate-reducing bacteria. • Allow more local nitrate-to-nitrite conversion. • Stimulate salivary flow. • Distribute nitrate throughout the oral cavity. • Provide a controlled and reproducible nitrate dose. • Repeatedly nourish nitrate-responsive organisms. • Support functional remodeling of the oral microbial community. This is the rationale behind the MyFitStrip™ nitric oxide delivery platform. The MyFitStrip™ Prebiotic Nitrate Platform MyFitStrip™ developed a localized, slow-release nitrate platform intended to work with the oral microbiome rather than bypass it. The strategy uses gum or lozenge delivery to extend nitrate “hang-time” in the mouth and provide nitrate directly to naturally occurring nitrate-reducing bacteria [41,42]. The formulation does not contain nitric oxide gas and does not directly force nitric oxide into the circulation. Instead, it supplies dietary nitrate as a prebiotic substrate and allows the oral microbiome to perform the first activation step. This distinction is fundamental. The MyFitStrip™ approach is designed to restore or strengthen a normal physiological function: the microbial conversion of dietary nitrate to nitrite. Clinical Validation of the Underlying Delivery Mechanism The localized MyFitStrip™ prebiotic nitrate strategy was evaluated in a randomized, double-blind, placebo-controlled clinical trial conducted at the University of Maryland [42]. Thirty adults received either a slow-release nitrate-containing MyFitStrip™ chewing gum or a matched placebo three times daily for 21 days. The study focused on oral inflammation, saliva, and the oral microbiome rather than sleep. Compared with baseline and placebo, the nitrate group demonstrated: • An approximately 40% reduction in mean bleeding on probing. • Increased salivary nitric oxide-related metabolites. • An increase in salivary pH. • Enrichment of nitrate-reducing organisms. • Increases in Rothia mucilaginosa and several Neisseria species. • Microbial changes associated with improved nitrate-reducing capacity. These results are consistent with the broader literature showing that nitrate can act as an oral prebiotic, enrich nitrate-reducing bacteria, increase oral pH, and favorably alter biofilm metabolism [35–40]. The trial provides clinical validation of the principal upstream mechanism: prolonged localized nitrate exposure can increase oral nitrate metabolism, shift the oral microbial community toward nitrate-reducing organisms, and generate measurable oral-health effects. The trial did not evaluate sleep, overnight oxygen saturation, snoring, or obstructive sleep apnea. It also directly evaluated the slow-release gum formulation rather than independently testing every finished lozenge format. The scientifically precise description is therefore that the MyFitStrip™ lozenge represents a clinically grounded translation of a validated slow-release prebiotic nitrate platform. The MyFitStrip™ Nitric Oxide Lozenge as a Practical Solution The MyFitStrip™ nitric oxide lozenge translates the same localized nitrate-delivery principle into a slowly dissolving format. As the lozenge dissolves, nitrate is released into saliva and presented to nitrate-reducing oral bacteria. The resulting nitrite can be swallowed, absorbed, and incorporated into the circulating nitrate–nitrite pool. The lozenge provides several practical advantages: • Direct delivery of nitrate to the oral microbiome. • Longer oral residence time than a capsule or beverage. • Stimulation of salivary flow. • A measured and reproducible nitrate source. • Support for nitrate-responsive oral bacteria. • A convenient format that does not require consuming a large volume of liquid. The lozenge should not be viewed simply as another nitrate supplement. Its distinguishing feature is localized microbial delivery. By placing nitrate where the first activation step occurs, the lozenge is intended to support both the immediate production of nitrite and the longer-term functional capacity of the oral microbial community. Why Use Before Sleep May Be Relevant The period before sleep is a logical time to examine this approach. Overnight food intake ceases, salivary production falls, and oral clearance slows. Some individuals also begin breathing through the mouth, further increasing oral dryness. A MyFitStrip™ lozenge allowed to dissolve completely before lying down could provide nitrate to the oral microbial community immediately before this overnight fasting period. A proposed sequence is: 1. The lozenge releases nitrate into saliva. 2. Oral bacteria convert nitrate into nitrite. 3. Nitrite-rich saliva is swallowed. 4. Nitrite and nitrate enter the circulation. 5. Circulating nitrate is recycled back into saliva. 6. Nitrite remains available for conversion to nitric oxide, particularly when oxygen tension falls. 7. Nasal breathing simultaneously delivers sinus-derived nitric oxide to the respiratory tract. 8. The endogenous, respiratory, and dietary pathways operate together during sleep. This model is biologically plausible, but the sleep-specific effects require direct testing. The pharmacokinetics of bedtime use, duration of increased salivary nitrite, and relationship to overnight physiology must be determined experimentally. The lozenge should dissolve fully before the individual lies down or falls asleep. It should not remain intact in the mouth during sleep because of choking or aspiration risk. Potential Relevance to Obstructive Sleep Apnea Obstructive sleep apnea is associated with intermittent hypoxia, oxidative stress, sympathetic activation, inflammation, endothelial dysfunction, and reduced nitric oxide bioavailability [27–31]. The nitrate–nitrite pathway is mechanistically attractive in this setting because nitrite reduction to nitric oxide becomes more favorable under low-oxygen conditions. A larger nitrate–nitrite reservoir could theoretically support nitric oxide formation during episodes of intermittent hypoxia. The MyFitStrip™ platform provides a practical means of testing this possibility because its ability to support salivary nitrate metabolism and nitrate-reducing bacteria has already been demonstrated clinically. However, neither the lozenge nor dietary nitrate has been established as a treatment for obstructive sleep apnea. The lozenge should not replace: • Continuous positive-airway-pressure therapy. • Mandibular advancement devices. • Weight management. • Positional therapy. • Surgery when medically indicated. • Evaluation and treatment of nasal obstruction. The appropriate hypothesis is that the lozenge may serve as an adjunctive nutritional and microbiome-directed strategy to support nitric oxide availability and vascular resilience. Clinical studies would need to evaluate apnea–hypopnea index, oxygen-desaturation index, minimum oxygen saturation, time below 90% saturation, nocturnal blood pressure, endothelial function, sleep-stage distribution, and waking performance. Potential Relevance to General Sleep Quality Nitric oxide participates in sleep pressure, adenosine signaling, cerebral perfusion, vascular relaxation, autonomic control, and respiratory physiology [5–9]. A nitrate lozenge should nevertheless not be described as a sedative. It does not act like melatonin, a benzodiazepine, or a conventional hypnotic medication. Its proposed role is physiological support. By supporting the oral nitrate–nitrite pathway, the lozenge may help maintain one of the systems involved in vascular regulation, oxygen handling, and restorative physiology during sleep. Insomnia remains multifactorial. Circadian disruption, stress, medications, pain, caffeine, alcohol, depression, anxiety, behavioral conditioning, and sleep environment may all be dominant contributors. The appropriate proposition is therefore that the MyFitStrip™ lozenge supports nitric oxide biology that may be relevant to sleep—not that it has been clinically proven to induce sleep or treat insomnia. Integrated Model The overall model can be summarized as follows: 1. The brain uses nitric oxide as part of sleep-homeostatic and neurovascular signaling. 2. Blood vessels use nitric oxide to regulate tone, perfusion, and oxygen delivery. 3. The paranasal sinuses generate nitric oxide that is delivered toward the lungs during nasal breathing. 4. Vegetables supply nitrate as a stable precursor. 5. Salivary glands concentrate circulating nitrate back into the mouth. 6. Oral bacteria reduce nitrate to nitrite. 7. Nitrite is swallowed and enters gastric and systemic nitric oxide pathways. 8. Nitrite reduction becomes more favorable when oxygen availability falls. 9. A slow-release MyFitStrip™ lozenge supplies nitrate directly to the oral microbial community. 10. Repeated exposure may strengthen the nitrate-reducing function of the oral microbiome. 11. The endogenous, nasal, dietary, and microbial pathways collectively support nitric oxide availability during the sleep period. Conclusion Nitric oxide connects the brain, vasculature, respiratory tract, diet, saliva, and oral microbiome. The endogenous nitric oxide synthase pathway supports neuronal signaling, vascular relaxation, cerebral perfusion, respiratory regulation, and sleep homeostasis. However, this pathway requires oxygen and can be impaired by aging, oxidative stress, inflammation, endothelial dysfunction, and intermittent hypoxia. Nasal breathing provides another source of nitric oxide. Sinus-derived nitric oxide is carried toward the lungs with inspired air and may support pulmonary vascular regulation, oxygen exchange, mucociliary function, and airway defense. The dietary nitrate–nitrite pathway provides a complementary source. Dietary nitrate is concentrated into saliva and reduced to nitrite by oral bacteria. Nitrite then serves as a reservoir for nitric oxide production, particularly under low-oxygen and acidic conditions. The oral microbiome is indispensable to this process. MyFitStrip™ ’s slow-release prebiotic nitrate platform provides a clinically studied strategy for supporting that microbial function. In a randomized, placebo-controlled trial, localized nitrate delivery increased salivary nitric oxide-related activity, raised oral pH, enriched nitrate-reducing bacteria, and reduced gingival inflammation. The MyFitStrip™ ™ nitric oxide lozenge translates this clinically validated mechanism into a practical, slowly dissolving formulation. By delivering nitrate directly to the oral microbial community, it provides a rational solution for supporting enterosalivary nitric oxide production before the overnight fasting period. The current evidence does not establish the lozenge as a treatment for insomnia, snoring, nocturnal hypoxemia, or obstructive sleep apnea. It does, however, identify a clinically grounded, biologically coherent, and testable strategy for supporting the nitric oxide systems relevant to vascular function, oxygen handling, nasal respiration, oral health, and restorative sleep. References 1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews. 1991;43(2):109–142. 2. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. European Heart Journal. 2012;33(7):829–837, 837a–837d. doi:10.1093/eurheartj/ehr304. 3. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nature Reviews Drug Discovery. 2008;7(2):156–167. doi:10.1038/nrd2466. 4. Lundberg JO, Carlström M, Weitzberg E. Metabolic effects of dietary nitrate in health and disease. Cell Metabolism. 2018;28(1):9–22. doi:10.1016/j.cmet.2018.06.007. 5. Gautier-Sauvigné S, Colas D, Parmantier P, et al. Nitric oxide and sleep. Sleep Medicine Reviews. 2005;9(2):101–113. doi:10.1016/j.smrv.2004.07.004. 6. Cespuglio R, Amrouni D, Meiller A, Buguet A, Gautier-Sauvigné S. Nitric oxide in the regulation of the sleep–wake states. Sleep Medicine Reviews. 2012;16(3):265–279. doi:10.1016/j.smrv.2012.01.006. 7. Kalinchuk AV, McCarley RW, Porkka-Heiskanen T, Basheer R. Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons. Journal of Neuroscience. 2010;30(40):13254–13264. doi:10.1523/JNEUROSCI.0014-10.2010. 8. Kalinchuk AV, Urrila AS, Alanko L, et al. Local energy depletion in the basal forebrain increases sleep. European Journal of Neuroscience. 2003;17(4):863–869. 9. Gerashchenko D, Wisor JP, Burns D, et al. Identification of a population of sleep-active cerebral cortex neurons. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(29):10227–10232. doi:10.1073/pnas.0803125105. 10. Koch CD, Gladwin MT, Freeman BA, Lundberg JO, Weitzberg E, Morris A. Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radical Biology and Medicine. 2017;105:48–67. doi:10.1016/j.freeradbiomed.2016.12.015. 11. Hezel MP, Weitzberg E. The oral microbiome and nitric oxide homeostasis. Oral Diseases. 2015;21(1):7–16. doi:10.1111/odi.12157. 12. Hyde ER, Andrade F, Vaksman Z, et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis. PLoS ONE. 2014;9(3):e88645. doi:10.1371/journal.pone.0088645. 13. L’Heureux JE, van der Giezen M, Winyard PG, Jones AM, Vanhatalo A. Localisation of nitrate-reducing and highly abundant microbial communities in the oral cavity. Scientific Reports. 2023;13:22572. doi:10.1038/s41598-023-49759-5. 14. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. New England Journal of Medicine. 2006;355(26):2792–2793. doi:10.1056/NEJMc062800. 15. Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008;51(3):784–790. doi:10.1161/HYPERTENSIONAHA.107.103523. 16. Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015;65(2):320–327. doi:10.1161/HYPERTENSIONAHA.114.04675. 17. Velmurugan S, Gan JM, Rathod KS, et al. Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study. American Journal of Clinical Nutrition. 2016;103(1):25–38. doi:10.3945/ajcn.115.116244. 18. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on oxygen cost during exercise. Acta Physiologica. 2007;191(1):59–66. doi:10.1111/j.1748-1716.2007.01713.x. 19. Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the oxygen cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. Journal of Applied Physiology. 2009;107(4):1144–1155. doi:10.1152/japplphysiol.00722.2009. 20. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nature Medicine. 1995;1(4):370–373. doi:10.1038/nm0495-370. 21. Lundberg JO, Weitzberg E. Nasal nitric oxide in man. Thorax. 1999;54(10):947–952. doi:10.1136/thx.54.10.947. 22. Lundberg JO. Nitric oxide and the paranasal sinuses. Anatomical Record. 2008;291(11):1479–1484. doi:10.1002/ar.20782. 23. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiologica Scandinavica. 1996;158(4):343–347. 24. Settergren G, Angdin M, Astudillo R, et al. Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses. Acta Physiologica Scandinavica. 1998;163(3):235–239. 25. Törnberg DCF, Marteus H, Schedin U, Alving K, Lundberg JO, Weitzberg E. Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients. European Respiratory Journal. 2002;19(5):859–864. doi:10.1183/09031936.02.00274902. 26. Weitzberg E, Lundberg JO. Humming greatly increases nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine. 2002;166(2):144–145. doi:10.1164/rccm.200202-138BC. 27. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Progress in Cardiovascular Diseases. 2009;51(5):351–362. doi:10.1016/j.pcad.2008.08.002. 28. Badran M, Golbidi S, Ayas N, Laher I. Nitric oxide bioavailability in obstructive sleep apnea: interplay of asymmetric dimethylarginine and free radicals. Sleep Disorders. 2015;2015:387801. doi:10.1155/2015/387801. 29. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270–2278. doi:10.1161/CIRCULATIONAHA.107.741512. 30. Ip MSM, Tse HF, Lam B, Tsang KWT, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. American Journal of Respiratory and Critical Care Medicine. 2004;169(3):348–353. doi:10.1164/rccm.200306-767OC. 31. Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pépin JL. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nature Reviews Cardiology. 2012;9(12):679–688. doi:10.1038/nrcardio.2012.141. 32. Govoni M, Jansson EÅ, Weitzberg E, Lundberg JO. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide. 2008;19(4):333–337. doi:10.1016/j.niox.2008.08.003. 33. Kapil V, Haydar SMA, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radical Biology and Medicine. 2013;55:93–100. doi:10.1016/j.freeradbiomed.2012.11.013. 34. Bondonno CP, Liu AH, Croft KD, et al. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. American Journal of Hypertension. 2015;28(5):572–575. doi:10.1093/ajh/hpu192. 35. Vanhatalo A, Blackwell JR, L’Heureux JE, et al. Nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood pressure in humans. Free Radical Biology and Medicine. 2018;124:21–30. doi:10.1016/j.freeradbiomed.2018.05.078. 36. Burleigh M, Liddle L, Monaghan C, et al. Dietary nitrate supplementation alters the oral microbiome but does not improve the vascular responses to an acute nitrate dose. Nitric Oxide. 2019;89:54–63. doi:10.1016/j.niox.2019.04.010. 37. Rosier BT, Moya-Gonzalvez EM, Corell-Escuin P, Mira A. Isolation and characterization of nitrate-reducing bacteria as potential probiotics for oral and systemic health. Frontiers in Microbiology. 2020;11:555465. doi:10.3389/fmicb.2020.555465. 38. Rosier BT, Buetas E, Moya-Gonzalvez EM, Artacho A, Mira A. Nitrate as a potential prebiotic for the oral microbiome. Scientific Reports. 2020;10:12895. doi:10.1038/s41598-020-69931-x. 39. Rosier BT, Takahashi N, Zaura E, et al. The importance of nitrate reduction for oral health. Journal of Dental Research. 2022;101(8):887–897. doi:10.1177/00220345221080982. 40. Moran SP, Harrington J, Cardwell CR, McGrath C, McKenna G. The effects of nitrate on the oral microbiome: a systematic review investigating prebiotic potential. Journal of Dentistry. 2024;143:104891. doi:10.1016/j.jdent.2024.104891. 41. Green SJ. Topical prebiotic nitrate: optimizing oral residence time, source, and dose to support nitrate reduction by the oral microbiome. npj Biofilms and Microbiomes. 2024;10. doi:10.1038/s41522-024-00527-3. 42. Yi B, Kim HY, Sotka W, Estey R, Green SJ, Shiau HJ. Localized prebiotic nitrate supplementation formula remodels oral biofilm metabolism and reduces gingival inflammation: a randomized placebo-controlled trial. medRxiv. 2026.